NIVOLUMAB | B125554 | BRISTOL MYERS SQUIBB
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Dec. 22, 2026 | Active | Computed |
| 7-Year Orphan | Apr. 13, 1931 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12410252(composition) · relevance 94/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 168 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.